N-(4-Methoxyphenyl)-N-(p-chlorobenzoyl)hydrazine
CAS : 16390-07-1
Ref. 3D-FM176935
| 100mg | Arrêté | ||
| 250mg | Arrêté |
Informations sur le produit
Nom :
N-(4-Methoxyphenyl)-N-(p-chlorobenzoyl)hydrazine
Synonymes :
- 4-Chloro-1'-(4-methoxyphenyl)benzohydrazide
- 4-Chlorobenzoic acid 1-(4-methoxyphenyl)hydrazide
- 4-chloro-N'-(4-methoxyphenyl)benzohydrazide
- Benzoic acid, 4-chloro-, 1-(4-methoxyphenyl)hydrazide
- Benzoic acid, p-chloro-, 1-(p-methoxyphenyl)hydrazide
- N-(4-Chlorobenzoyl)-N-(4-methoxyphenyl)hydrazine
- N-(p-Chlorobenzoyl)-N-(p-methoxyphenyl)hydrazine
- N-4-Methoxyphenyl-N-4-chlorobenzoylhydrazide
Description :
N-(4-Methoxyphenyl)-N-(p-chlorobenzoyl)hydrazine is a nonselective, nonsteroidal anti-inflammatory drug that inhibits the production of inflammatory prostaglandins. It has been shown to inhibit prostate cancer cells in cell-based assays. This drug has a bioisosteric and bioisosteres relationship with piroxicam, which is also a nonselective, nonsteroidal anti-inflammatory. N-(4-Methoxyphenyl)-N-(p-chlorobenzoyl)hydrazine may be useful in the treatment of prostate cancer because it prevents the production of inflammatory prostaglandins.
Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :
Propriétés chimiques
Masse moléculaire :
276.72 g/mol
Formule :
C14H13ClN2O2
Degré de pureté :
Min. 95%
MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :
